I Cavero
Overview
Explore the profile of I Cavero including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
135
Citations
880
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Calderone V, Cavero I
Minerva Med
. 2002 Jul;
93(3):181-97.
PMID: 12094149
The electrocardiogram shows a sequence of cardiac electrical events generated by individual electrical currents generated mainly by sodium (Na+), potassium (K+) and calcium (Ca++) ions transiting via specialized transport pathways,...
2.
Cavero I, Mestre M, Guillon J, Crumb W
Expert Opin Pharmacother
. 2001 Mar;
1(5):947-73.
PMID: 11249502
Medicinal products that, as an unwanted effect, prolong the QT interval of the electrocardiogram (ECG) can trigger episodes of polymorphic ventricular dysrhythmias, called torsades de pointes, which occasionally culminate in...
3.
Mestre M, Djellas Y, Carriot T, Cavero I
Fundam Clin Pharmacol
. 2000 May;
14(2):107-17.
PMID: 10796057
The Na+ channel blocking activity and the antiarrhythmic effects of riluzole, and established anticonvulsants (lamotrigine and lifarizine) and class I antiarrhythmics (lidocaine, flecainide and disopyramide) were studied under in vitro...
4.
Cavero I, Mestre M, Guillon J, Heuillet E, Roach A
Drug Saf
. 1999 Dec;
21 Suppl 1:19-31; discussion 81-7.
PMID: 10597865
The cardiac action potential results from a dynamic balance between inward depolarising Na+ and Ca2+ currents and outward K+ repolarising currents. During a cardiac cycle, the resultant of repolarisation phase...
5.
Auchampach J, Pieper G, Cavero I, Gross G
Basic Res Cardiol
. 1998 Dec;
93(5):361-71.
PMID: 9833148
The effect of the platelet activating factor antagonist RP 59227 (Tulopafant) on myocardial infarct size was compared to that of a vehicle-treated control group in barbital-anesthetized dogs subjected to 90...
6.
Magnon M, Calderone V, Floch A, Cavero I
Naunyn Schmiedebergs Arch Pharmacol
. 1998 Nov;
358(4):452-63.
PMID: 9826068
We examined the effects of various KCl concentrations on the actions of some vasodilators belonging to different pharmacological classes in rat aortic rings. In some experiments, tissues were precontracted with...
7.
Guillon J, Thiry C, Roach A, Cavero I
J Cardiovasc Pharmacol
. 1998 May;
31 Suppl 1:S133-7.
PMID: 9595421
The effects of vasodepressor (acetylcholine and bradykinin) and pressor [electrical stimulation of the spinal sympathetic outflow, norepinephrine and endothelin-1 (ET-1)] stimuli were determined in rats with 2- and 5-week untreated...
8.
Schultz J, Yao Z, Cavero I, Gross G
Am J Physiol
. 1997 Jun;
272(6 Pt 2):H2607-15.
PMID: 9227537
The ATP-sensitive potassium (KATP) channel has been demonstrated to be a potential mediator of ischemic preconditioning (PC) in most species, with the exception of the rat. This conclusion is based...
9.
Belin V, Hodge T, Picaut P, Jordan R, Algate C, Gosselin S, et al.
Fundam Appl Toxicol
. 1996 Jun;
31(2):259-67.
PMID: 8789792
Aprikalim is a potent, specific, and selective opener of ATP-sensitive K+ (KATP) channels. By virtue of this pharmacological property, aprikalim affords cardioprotection in experimental models of ischemia/reperfusion injury, and, at...
10.
Floch A, Thiry C, Cavero I
Fundam Clin Pharmacol
. 1996 Jan;
10(4):337-43.
PMID: 8871132
Vascular NK-1 and NK-2 tachykinin receptors in the rat and the guinea pig were characterized pharmacologically by using available agonists and antagonists exhibiting varying degrees of selectivity for these receptors....